Blood Test Using Exosomes Shows Promise for Monitoring Rare Sarcoma Cancers
French study explores how tiny cellular packages in blood could predict cancer recurrence and guide treatment decisions.
20 articles
French study explores how tiny cellular packages in blood could predict cancer recurrence and guide treatment decisions.
A Phase 2 trial tests a GalNAc-conjugated antisense therapy in familial partial lipodystrophy patients with dangerously high triglycerides.
Small study explores cerebrospinal fluid exosomes to better diagnose breast cancer spread to brain and spinal cord.
Study explores how genetic variants influence whether plant-based or animal-based diets trigger inflammation and alter gut microbiome.
176-person study explored personalized responses to refined carbs, whole grains, and intermittent fasting for optimal glucose control.
New diagnostic chip analyzes blood exosomes to detect early lung spread of bone cancer, potentially improving treatment outcomes.
A completed French trial explores how gut and airway microbiota, blood, and sputum biomarkers relate to immunotherapy outcomes in metastatic NSCLC.
New liquid biopsy technique identifies molecular residual disease in colorectal cancer patients to guide personalized treatment decisions.
Italian researchers developed a biosensor to track extracellular vesicles in blood, potentially personalizing stroke rehabilitation.
Researchers analyzed epigenetic changes in 124 Israeli centenarians to understand the molecular basis of exceptional longevity.
Small study reveals how exercise plus protein intake triggers beneficial gene changes in older women at metabolic risk.
A completed Phase 3 trial tests placental MSC secretome injections against placebo in 60 GvHD patients at an Iranian hospital.
A Phase 2 trial combining adaptive stereotactic radiotherapy with IMSA101 and checkpoint inhibitors was halted after enrolling only 16 patients.
Researchers developed retinal imaging techniques to identify Alzheimer's biomarkers decades before clinical diagnosis.
Small pilot study examined psilocybin's effects on brain circuits and emotion processing in healthy adults to understand abuse potential.
Researchers explored whether cancer-derived cell-free DNA and telomere maintenance mutations could serve as early warning biomarkers in soft tissue sarcoma patients.
Comprehensive analysis of 100 centenarians identifies key biological markers associated with reaching 100+ years of age.
Researchers used retinal imaging to detect brain amyloid and tested whether telomerase activation could reduce Alzheimer's markers.
New study shows how analyzing fluid from lungs can detect cancer mutations and guide personalized treatment decisions.
A French trial investigated whether circulating immune cell profiles, specifically CD226 expression, could predict who responds to Atezolizumab/Bevacizumab in advanced HCC.